| Serial Number | 79413314 |
| Word Mark | CYCURIA |
| Filing Date | Tuesday, November 12, 2024 |
| Status | 680 - APPROVED FOR PUBLICATION |
| Status Date | Saturday, December 20, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Scientific services and research relating thereto, namely, scientific research; Scientific services and research relating thereto, namely, scientific research and development; Scientific services and research relating thereto, namely, scientific research for medical purposes in the field of cancerous diseases; Scientific services and research relating thereto, namely, scientific research, analysis, and testing in the fields of genomics, genetics, genetic engineering, biotechnology, and medicine; Scientific services and research relating thereto, namely, providing scientific research information in the field of genetics; Scientific services and research relating thereto, namely, providing scientific research information in the field of pharmaceuticals; Scientific services and research relating thereto, namely, scientific laboratory services; Scientific services and research relating thereto, namely, scientific research and scientific research information in the field of pharmaceuticals and clinical trials and conducting clinical trials for others; scientific services and research relating thereto, namely, scientific research, scientific research and development, analysis, and testing, and providing of scientific research information in the fields of biology, chemistry or medicine, as well as in the fields of immunology, oncology, molecular biology, cellular biology, biochemistry and medicinal chemistry as well as in the fields of discovery and development of pharmaceuticals, medical and veterinary preparations, diagnostic preparations and biomarker reagents and diagnostic apparatus; scientific services and research thereto, namely, scientific research, scientific research and development, analysis, and testing, and providing of scientific research information in the field of discovery of drug targets and drug candidates for the treatment or diagnostics of diseases, disorders and conditions in humans and animals, in particular in the fields of oncology, inflammatory-, autoimmune- and metabolic diseases; providing technical and scientific information about a biotechnology company, its technologies, projects, product-candidates, products and services via a web site on a global computer network; design and development of computer software; design and development of computer software for use in the fields of biology, chemistry or medicine, especially immunology, oncology, molecular biology, cellular biology, biochemistry and/or medicinal chemistry, as well as in the fields of discovery and development of pharmaceuticals, medical and veterinary preparations, diagnostic preparations and biomarker reagents and diagnostic apparatus. |
| Goods and Services | Pharmaceutical preparations and formulations, and medicated health preparations, for use in the treatment or prevention of human and animal diseases, disorders and conditions, especially circulatory, respiratory, endocrine, neurologic, cardiovascular, alimentary, pulmonary, musculoskeletal, lymphatic and gastrointestinal diseases, disorders and conditions, and the treatment or prevention of complications associated with such diseases, disorders and conditions; pharmaceutical preparations and formulations, and medicated health preparations, for use in the treatment or prevention of human and animal diseases, disorders and conditions, especially bone sensory, viral, urinary, renal, metabolic and central nervous system diseases, disorders and conditions, and the treatment or prevention of complications associated with such diseases, disorders and conditions; pharmaceutical preparations and formulations, and medicated health preparations, for use in the treatment or prevention of human and animal diseases, disorders and conditions, especially infectious, auto-immune and immune-related, cell-proliferative and oncologic diseases, disorders and conditions, cancers, tumours and metastases, and the treatment or prevention of complications associated with such diseases, disorders and conditions; diagnostic preparations and biomarker reagents for medical or veterinary purposes; diagnostic preparations and biomarker reagents for the diagnosis and prognosis of human and animal diseases, disorders and conditions, especially circulatory, respiratory, endocrine, neurologic, cardiovascular, alimentary, pulmonary, musculoskeletal, lymphatic and gastrointestinal diseases, disorders and conditions, and the diagnosis and prognosis of complications associated with such diseases, disorders and conditions; diagnostic preparations and biomarker reagents for the diagnosis and prognosis of human and animal diseases, disorders and conditions, especially bone sensory, viral, urinary, renal, metabolic and central nervous system diseases, disorders and conditions, and the diagnosis and prognosis of complications associated with such diseases, disorders and conditions; diagnostic preparations and biomarker reagents for the diagnosis and prognosis of human and animal diseases, disorders and conditions, especially infectious, auto-immune and immune-related, cell-proliferative and oncologic diseases, disorders and conditions, cancers, tumours and metastases, and the diagnosis and prognosis of complications associated with such diseases, disorders and conditions. |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, December 26, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, December 26, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Cycuria Therapeutics GmbH |
| Party Type | 11 - New Owner Before Publication |
| Legal Entity Type | 99 - Other |
| Address | AT |
| Party Name | Cycuria GmbH |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 27 - NOT AVAILABLE |
| Address | A-8010 Graz AT |
| Event Date | Event Description |
| Thursday, December 26, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, December 27, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, December 27, 2024 | APPLICATION FILING RECEIPT MAILED |
| Friday, February 14, 2025 | CORRECTION TRANSACTION RECEIVED FROM IB |
| Tuesday, April 15, 2025 | ASSIGNED TO EXAMINER |
| Wednesday, April 23, 2025 | NON-FINAL ACTION WRITTEN |
| Thursday, April 24, 2025 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Sunday, June 22, 2025 | REFUSAL PROCESSED BY MPU |
| Sunday, June 22, 2025 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Saturday, July 12, 2025 | REFUSAL PROCESSED BY IB |
| Tuesday, August 12, 2025 | CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED |
| Thursday, August 28, 2025 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
| Friday, December 19, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, December 19, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, December 19, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Saturday, December 20, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |